Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
出版年份 2021 全文链接
标题
Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
作者
关键词
-
出版物
Science Advances
Volume 7, Issue 43, Pages -
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-10-22
DOI
10.1126/sciadv.abj3107
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
- (2021) Yin-Feng Kang et al. ACS Nano
- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
- (2021) Philip J.M. Brouwer et al. CELL
- B cell memory: Understanding COVID-19
- (2021) Isaak Quast et al. IMMUNITY
- Vaccinology in the post−COVID-19 era
- (2021) Rino Rappuoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
- (2021) Tiong Kit Tan et al. Nature Communications
- A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
- (2021) Abigail E. Powell et al. ACS Central Science
- No higher infectivity but immune escape of SARS-CoV-2 501Y.V2 variants
- (2021) Qianqian Li et al. CELL
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
- (2021) Fang Chen et al. IMMUNITY
- SARS-CoV-2 Viral Variants—Tackling a Moving Target
- (2021) John R. Mascola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
- (2021) Peter Richmond et al. LANCET
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- Dynamic regulation of TFH selection during the germinal centre reaction
- (2021) Julia Merkenschlager et al. NATURE
- Variant-proof vaccines — invest now for the next pandemic
- (2021) Dennis R. Burton et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- Assessing the human immune response to SARS-CoV-2 variants
- (2021) Roberto Burioni et al. NATURE MEDICINE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
- (2021) Joshua G. Liang et al. Nature Communications
- Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
- (2021) Robert Challen et al. BMJ-British Medical Journal
- A lymph node–targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2
- (2021) Martin P. Steinbuck et al. Science Advances
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines
- (2021) Linling He et al. Nature Communications
- SARS-CoV-2 evolution and vaccines: cause for concern?
- (2021) Thomas C Williams et al. Lancet Respiratory Medicine
- Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
- (2021) Linling He et al. Science Advances
- Protein-based antigen presentation platforms for nanoparticle vaccines
- (2021) Brian Nguyen et al. npj Vaccines
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Delta coronavirus variant: scientists brace for impact
- (2021) Ewen Callaway NATURE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles
- (2021) Sonu Kumar et al. mBio
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Toll-like Receptors and the Control of Immunity
- (2020) Katherine A. Fitzgerald et al. CELL
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- A strategic approach to COVID-19 vaccine R&D
- (2020) Lawrence Corey et al. SCIENCE
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines
- (2020) Linling He et al. Science Advances
- Suppressing Subcapsular Sinus Macrophages Enhances Transport of Nanovaccines to Lymph Node Follicles for Robust Humoral Immunity
- (2020) Yi-Nan Zhang et al. ACS Nano
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- COVID-19 vaccine development and a potential nanomaterial path forward
- (2020) Matthew D. Shin et al. Nature Nanotechnology
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans
- (2020) Gui-Ping Wen et al. Nature Communications
- Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
- (2020) Yu Kato et al. IMMUNITY
- Animal models for COVID-19
- (2020) César Muñoz-Fontela et al. NATURE
- Whither COVID-19 vaccines?
- (2020) Laura DeFrancesco NATURE BIOTECHNOLOGY
- A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone
- (2020) Baoshan Zhang et al. Scientific Reports
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
- (2020) Yuezhou Chen et al. CELL
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
- (2020) Katlyn Lederer et al. IMMUNITY
- Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
- (2020) Xiancai Ma et al. IMMUNITY
- Eliciting B cell immunity against infectious diseases using nanovaccines
- (2020) Ankur Singh Nature Nanotechnology
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Self-Assembling Nanoparticles Usher in a New Era of Vaccine Design
- (2019) Rino Rappuoli et al. CELL
- Nanoparticle Size Influences Antigen Retention and Presentation in Lymph Node Follicles for Humoral Immunity
- (2019) Yi-Nan Zhang et al. NANO LETTERS
- Induction of broadly neutralizing antibodies in Germinal Centre simulations
- (2018) Philippe A Robert et al. CURRENT OPINION IN BIOTECHNOLOGY
- Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses
- (2018) Girja S. Shukla et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Glycoconjugate vaccines: Principles and mechanisms
- (2018) Rino Rappuoli Science Translational Medicine
- Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
- (2018) Talar Tokatlian et al. SCIENCE
- An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers
- (2017) Limin Wijaya et al. VACCINE
- Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers
- (2017) Charles D. Morris et al. mBio
- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- Programming of donor T cells using allogeneic -like ligand 4-positive dendritic cells to reduce GVHD in mice
- (2016) K. Mochizuki et al. BLOOD
- Germinal Center B Cell Dynamics
- (2016) Luka Mesin et al. IMMUNITY
- Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection
- (2016) Laura M. Snell et al. Cell Reports
- Self-assembling protein nanoparticles in the design of vaccines
- (2016) Jacinto López-Sagaseta et al. Computational and Structural Biotechnology Journal
- Vaccine Adjuvant MF59 Promotes Retention of Unprocessed Antigen in Lymph Node Macrophage Compartments and Follicular Dendritic Cells
- (2015) Rocco Cantisani et al. JOURNAL OF IMMUNOLOGY
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
- (2011) Tracy L Flach et al. NATURE MEDICINE
- Differentiation of Effector CD4 T Cell Populations
- (2010) Jinfang Zhu et al. Annual Review of Immunology
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- B cell follicles and antigen encounters of the third kind
- (2010) Jason G Cyster NATURE IMMUNOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Cloning and expression of murine Ig genes from single B cells
- (2009) Thomas Tiller et al. JOURNAL OF IMMUNOLOGICAL METHODS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now